Spanish doctors and researchers credit medical new idea and close cooperation between researchers and the pharmaceutical industry with extending the lives of patients with multiple myeloma. Event participants have described survival gains as threefold, and some patients achieve functional remission, though the claim is not a confirmed national average.
Philips is rolling out AI-powered diagnostic tools across Spain, pushing hospitals to rethink how they deliver care. Miguel de Foronda says only real, able to grow new idea can keep up with growing patient needs.
AbbVie’s top executive in Spain warns that the country could lose its place in global medical new idea unless it increases investment and reforms the system. He calls for bold moves to keep Spain competitive as Europe trails the US and China.
Nearly 50 young endocrinology specialists met in Madrid for the first Emerging Experts programme. The training focused on chronic hypoparathyroidism, a rare disease estimated to affect around 13,000 people in Spain.
Zepzelca, PharmaMar’s treatment for small cell lung cancer, remains out of reach for European patients as regulatory and reimbursement processes drag on. Despite its proven benefits and US approval, the drug’s future in Spain depends on government action and industry support.
Spain’s generic drug sector is warning that government price controls are pushing prices to unsustainable lows and putting the country’s ability to guarantee critical medicines at risk.
Incyte Biosciences Iberia has invested €130 million in Spanish R&D and clinical trials, but patients still wait too long for new treatments. Company leaders want clearer agreements and quicker approvals to match Spain’s scientific strength.
Spain’s pharmacist-owned pharmacy system is under pressure from foreign groups and regulatory changes. Industry leaders warn that healthcare access and rural cohesion could be at risk if the model is undermined.
Healthcare is now the basic battleground for the Partido Popular as elections approach. Carmen Fúnez has pledged a major overhaul of Spain's health system, focused on a unified system and support for healthcare professionals, backed by stable funding.
Spain’s pharmaceutical leaders are calling for greater autonomy in medicine manufacturing. At a Madrid symposium, industry figures outlined how new idea and public policy, backed by cross-border alliances, could protect Europe from future supply shocks.
Spain's doctors have postponed their indefinite stoppage planned for 28 October after an early general election was called for 29 November 2026. The strike remains active and could resume if the next Government does not address demands for a separate medical statute.
At 33, Bárbara Burgos Blasco has been recognized as Spain’s leading young ophthalmologist. The Arruga 2026 award recognizes her work in research and teaching, along with her clinical care at Hospital Clínico San Carlos.
At Hospital Universitario Fundación Jiménez Díaz, specialists showed patients and trainees how hematology care draws on blood counts and cellular studies, with genetic tests adding further detail. The meeting also covered new treatments and transfusion support, alongside research and patient services.
Women report more pain across most stages of life. Researchers link the gap to physiology and to the combined effects of paid work and unequal family care.
Vitamin D levels may fall as October brings less useful sunlight, but no Spanish study cited here confirms that more than 60% of Spanish adults are affected. Testing matters because excess supplements can damage health.
Researchers in Barcelona identified p38a as a possible target in melanoma. Blocking the protein strengthened anti-PD-1 treatment in animal models and sometimes cleared tumours completely, but the findings remain preclinical.
Only 27% of Spanish parents know meningitis can become fatal within hours. Awareness is even lower among teenagers, despite the risk of lasting damage.
A Vall d'Hebron study points to p38a as a possible melanoma treatment target. Blocking the protein improved anti-PD-1 therapy in animal models, while a nine-gene profile may help identify tumours more likely to respond.
Roche has begun selling Xofluza in Spain. The oral antiviral blocks flu replication early and is taken in one dose within 48 hours.
Vall d'Hebron researchers identified p38α as a possible target in melanoma treatment. Blocking the protein improved anti-PD-1 responses in experimental models and revealed a nine-gene signature linked to treatment outcomes.
Meningitis can worsen quickly, and its first signs may look ordinary. High fever and severe headache, especially with neck stiffness, need urgent medical assessment.
A Catalan study of 30,000 PCR samples found Covid peaks in August and September. The pattern has reopened debate over the timing of autumn vaccination, but researchers say more evidence is needed.
The European Commission has approved ICOTYDE® for eligible psoriasis patients aged 12 and over who weigh at least 40kg. The once-daily oral peptide targets IL-23 directly and is backed by phase III data from about 2,500 participants.
Companies selling alternative menopause hormone treatments have declined public funding. Supply failures are squeezing patches and sprays as Sanidad seeks another way forward.
More than 350 specialists met in Barcelona to discuss earlier rheumatoid arthritis diagnosis. Biomarkers and ultrasound are helping doctors spot the disease sooner and tailor treatment for thousands of patients in Spain.
Lenzetto shortages are disrupting access to transdermal hormone treatments in Spain. Alternative patches are under pressure as regulators seek more supply and clinical guidance.
Around 20,000 new cases are diagnosed in Spain each year. Earlier detection and targeted therapies are helping doctors protect mobility and quality of life.
Spain's public health leaders met to examine the system's next challenges. The debate focused on how regional responsibility intersects with national coordination, and what those arrangements mean for the system's ability to recover.
A new white paper sets out 14 recommendations for flu prevention in Spain. It ties vaccination coverage to access and coordination, with protection focused on people at higher risk.
A review in Science examines why women experience chronic pain at roughly twice the rate of men. Sex hormones may shape pain sensitivity and immune responses, while also influencing how pain is processed across the body.
Spain's respiratory-infection rate rose 28.2% in one week and crossed the epidemic threshold. COVID-19 is driving the increase, while hospital pressure remains limited but measurable.
About 300,000 people in Spain live with inflammatory bowel disease. GETECCU and ACCU are calling for faster diagnosis and equal access to specialist treatment, with regular psychological support.
GETECCU and ACCU España have presented a ten-point plan for inflammatory bowel disease care in Spain. The groups say access to specialist units and treatment still varies between autonomous communities.
Researchers at Barcelona's Instituto de Investigación Sant Pau are challenging the idea that depression has one biological pattern. Their review links anhedonia and rumination to distinct patterns of brain connectivity. It also links insomnia and suicidal behaviour to other patterns.
Spain has crossed the epidemic threshold for acute respiratory infections. Coronavirus now leads primary care detections and respiratory hospital admissions, while demand for home tests is rising.
